Business Context and Reporting Period
This Form 8-K filing by Cue Biopharma, Inc. reports a change in the company's certifying accountant. The report date is June 21, 2018, covering events occurring on that date regarding the dismissal of the previous auditor and the appointment of a new one.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and audit matters.
Material Changes
- Dismissal of Auditor: On June 21, 2018, the Audit Committee dismissed Gumbiner Savett Inc. as the independent registered public accounting firm.
- Appointment of New Auditor: On June 21, 2018, the Audit Committee appointed RSM US LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2018.
- Audit History: Gumbiner Savett Inc. issued reports for the past two fiscal years with no adverse opinions or disclaimers. However, the report for the year ended December 31, 2016, included an explanatory paragraph regarding substantial doubt as to the Company's ability to continue as a going concern.
- Internal Controls: The Company previously identified a material weakness in internal control over financial reporting related to a lack of effective controls for access restriction and segregation of duties due to limited accounting staff. The Company states this weakness has been remediated.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary on business operations. The primary risk disclosed relates to the historical material weakness in internal controls, which the company asserts has been resolved. There were no disagreements with the former auditor regarding accounting principles or audit scope during the two most recent fiscal years.
Investor Verification Checklist
- Verify the status of the remediation of the material weakness in internal controls over financial reporting.
- Review the letter from Gumbiner Savett Inc. (Exhibit 16) to confirm their agreement with the Company's statements regarding the dismissal.
- Confirm the transition timeline and scope of work for the new auditor, RSM US LLP.
- Assess the current liquidity position given the historical "going concern" qualification noted in the 2016 audit report.